<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Proc Natl Acad Sci U S A</journal-id>
<journal-id journal-id-type="iso-abbrev">Proc. Natl. Acad. Sci. U.S.A</journal-id>
<journal-id journal-id-type="hwp">pnas</journal-id>
<journal-id journal-id-type="pmc">pnas</journal-id>
<journal-id journal-id-type="publisher-id">PNAS</journal-id>
<journal-title-group>
<journal-title>Proceedings of the National Academy of Sciences of the United States of America</journal-title>
</journal-title-group>
<issn pub-type="ppub">0027-8424</issn>
<issn pub-type="epub">1091-6490</issn>
<publisher>
<publisher-name>National Academy of Sciences</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28584132</article-id>
<article-id pub-id-type="pmc">5488945</article-id>
<article-id pub-id-type="publisher-id">201702723</article-id>
<article-id pub-id-type="doi">10.1073/pnas.1702723114</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>PNAS Plus</subject>
</subj-group>
<subj-group subj-group-type="heading">
<subject>Biological Sciences</subject>
<subj-group>
<subject>Genetics</subject>
</subj-group>
</subj-group>
<series-title>PNAS Plus</series-title>
</article-categories>
<title-group>
<article-title>Transposon mutagenesis identifies chromatin modifiers cooperating with <italic>Ras</italic> in thyroid tumorigenesis and detects <italic>ATXN7</italic> as a cancer gene</article-title>
<alt-title alt-title-type="short">Chromatin modifiers and RAS-driven thyroid cancer</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Montero-Conde</surname>
<given-names>Cristina</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>b</sup>
</xref>
<xref ref-type="author-notes" rid="fn1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Leandro-Garcia</surname>
<given-names>Luis J.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
<xref ref-type="author-notes" rid="fn1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chen</surname>
<given-names>Xu</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Oler</surname>
<given-names>Gisele</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ruiz-Llorente</surname>
<given-names>Sergio</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ryder</surname>
<given-names>Mabel</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Landa</surname>
<given-names>Iñigo</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sanchez-Vega</surname>
<given-names>Francisco</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>c</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>La</surname>
<given-names>Konnor</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>c</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ghossein</surname>
<given-names>Ronald A.</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>d</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bajorin</surname>
<given-names>Dean F.</given-names>
</name>
<xref ref-type="aff" rid="aff5">
<sup>e</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Knauf</surname>
<given-names>Jeffrey A.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Riordan</surname>
<given-names>Jesse D.</given-names>
</name>
<xref ref-type="aff" rid="aff6">
<sup>f</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Dupuy</surname>
<given-names>Adam J.</given-names>
</name>
<xref ref-type="aff" rid="aff6">
<sup>f</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Fagin</surname>
<given-names>James A.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
<xref ref-type="aff" rid="aff5">
<sup>e</sup>
</xref>
<xref ref-type="corresp" rid="cor1">
<sup>2</sup>
</xref>
</contrib>
<aff id="aff1"><sup>a</sup>Human Oncology and Pathogenesis Program, <institution>Memorial Sloan Kettering Cancer Center</institution>, New York, <addr-line>NY</addr-line> 10065;</aff>
<aff id="aff2"><sup>b</sup>Hereditary Endocrine Cancer Group, <institution>Spanish National Cancer Research Center</institution>, Madrid, <country>Spain</country> 28029;</aff>
<aff id="aff3"><sup>c</sup>Center for Molecular Oncology, <institution>Memorial Sloan Kettering Cancer Center</institution>, New York, <addr-line>NY</addr-line> 10065;</aff>
<aff id="aff4"><sup>d</sup>Department of Pathology, <institution>Memorial Sloan Kettering Cancer Center</institution>, New York, <addr-line>NY</addr-line> 10065;</aff>
<aff id="aff5"><sup>e</sup>Department of Medicine, <institution>Memorial Sloan Kettering Cancer Center</institution>, New York, <addr-line>NY</addr-line> 10065;</aff>
<aff id="aff6"><sup>f</sup>Department of Anatomy and Cell Biology, <institution>University of Iowa</institution>, Iowa City, <addr-line>IA</addr-line> 52242</aff>
</contrib-group>
<author-notes>
<corresp id="cor1"><sup>2</sup>To whom correspondence should be addressed. Email: <email>faginj@mskcc.org</email>.</corresp>
<fn fn-type="edited-by">
<p>Edited by Albert de la Chapelle, Ohio State University Comprehensive Cancer Center, Columbus, OH, and approved May 16, 2017 (received for review February 16, 2017)</p>
</fn>
<fn fn-type="con">
<p>Author contributions: C.M.-C., L.J.L.-G., X.C., S.R.-L., I.L., J.A.K., J.D.R., A.J.D., and J.A.F. designed research; C.M.-C., L.J.L.-G., X.C., G.O., S.R.-L., M.R., I.L., R.A.G., J.D.R., and A.J.D. performed research; J.D.R. and A.J.D. contributed new reagents/analytic tools; C.M.-C., L.J.L.-G., F.S.-V., K.L., R.A.G., D.F.B., J.A.K., J.D.R., A.J.D., and J.A.F. analyzed data; and C.M.-C., L.J.L.-G., and J.A.F. wrote the paper.</p>
</fn>
<fn fn-type="equal" id="fn1">
<p><sup>1</sup>C.M.-C. and L.J.L.-G. contributed equally to this study.</p>
</fn>
<fn fn-type="COI-statement">
<p>The authors declare no conflict of interest.</p>
</fn>
</author-notes>
<pub-date pub-type="ppub">
<day>20</day>
<month>6</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="epub">
<day>5</day>
<month>6</month>
<year>2017</year>
</pub-date>
<volume>114</volume>
<issue>25</issue>
<fpage>E4951</fpage>
<lpage>E4960</lpage>
<permissions></permissions>
<self-uri xlink:href="pnas.201702723.pdf" xlink:title="pdf"></self-uri>
<abstract abstract-type="executive-summary">
<title>Significance</title>
<p>Mutations of RAS are believed to be early events in thyroid tumorigenesis but are insufficient to induce transformation. A forward genetic screen with transposons engineered to integrate randomly into the mouse Ras-mutant thyroid cell genome and to disrupt genes at their insertion sites resulted in tumors that phenocopied human RAS-driven, poorly differentiated thyroid cancers. Analysis of the transposon-integration sites revealed recurrent mutations of chromatin modifiers and PI3K pathway genes, consistent with mutations seen in human advanced thyroid cancers. These human cancers have a high mutation burden, which confounds distinctions between driver and passenger mutations. This unbiased screen for genes selected during tumorigenesis provides strong functional support for genetic disruptions in these pathways in RAS-induced thyroid tumor progression.</p>
</abstract>
<abstract>
<p>Oncogenic <italic>RAS</italic> mutations are present in 15–30% of thyroid carcinomas. Endogenous expression of mutant Ras is insufficient to initiate thyroid tumorigenesis in murine models, indicating that additional genetic alterations are required. We used Sleeping Beauty (SB) transposon mutagenesis to identify events that cooperate with Hras<sup>G12V</sup> in thyroid tumor development. Random genomic integration of SB transposons primarily generated loss-of-function events that significantly increased thyroid tumor penetrance in <italic>Tpo-Cre/homozygous FR-Hras</italic><sup><italic>G12V</italic></sup> mice. The thyroid tumors closely phenocopied the histological features of human RAS-driven, poorly differentiated thyroid cancers. Characterization of transposon insertion sites in the SB-induced tumors identified 45 recurrently mutated candidate cancer genes. These mutation profiles were remarkably concordant with mutated cancer genes identified in a large series of human poorly differentiated and anaplastic thyroid cancers screened by next-generation sequencing using the MSK-IMPACT panel of cancer genes, which we modified to include all SB candidates. The disrupted genes primarily clustered in chromatin remodeling functional nodes and in the PI3K pathway. <italic>ATXN7</italic>, a component of a multiprotein complex with histone acetylase activity, scored as a significant SB hit. It was recurrently mutated in advanced human cancers and significantly co-occurred with <italic>RAS</italic> or <italic>NF1</italic> mutations. Expression of <italic>ATXN7</italic> mutants cooperated with oncogenic RAS to induce thyroid cell proliferation, pointing to <italic>ATXN7</italic> as a previously unrecognized cancer gene.</p>
</abstract>
<kwd-group>
<kwd>thyroid cancer genomics</kwd>
<kwd>Sleeping Beauty</kwd>
<kwd>Ras</kwd>
<kwd>Swi/Snf</kwd>
<kwd>Pten</kwd>
</kwd-group>
<funding-group>
<award-group id="gs1">
<funding-source id="sp1">HHS | NIH | National Cancer Institute (NCI)<named-content content-type="funder-id">100000054</named-content></funding-source>
<award-id rid="sp1">2RO1-CA50706</award-id>
</award-group>
<award-group id="gs2">
<funding-source id="sp2">HHS | NIH | National Cancer Institute (NCI)<named-content content-type="funder-id">100000054</named-content></funding-source>
<award-id rid="sp2">2RO1-CA72597</award-id>
</award-group>
<award-group id="gs3">
<funding-source id="sp3">HHS | NIH | National Cancer Institute (NCI)<named-content content-type="funder-id">100000054</named-content></funding-source>
<award-id rid="sp3">P50-CA72012</award-id>
</award-group>
<award-group id="gs4">
<funding-source id="sp4">HHS | NIH | National Cancer Institute (NCI)<named-content content-type="funder-id">100000054</named-content></funding-source>
<award-id rid="sp4">P30-CA008748</award-id>
</award-group>
<award-group id="gs5">
<funding-source id="sp5">Fundación Científica Asociación Española Contra el Cáncer (Scientific Foundation, Spanish Association Against Cancer)<named-content content-type="funder-id">501100002704</named-content></funding-source>
<award-id rid="sp5">NA</award-id>
</award-group>
<award-group id="gs6">
<funding-source id="sp6">Memorial Sloan-Kettering Cancer Center (MSKCC)<named-content content-type="funder-id">100007052</named-content></funding-source>
<award-id rid="sp6">NA</award-id>
</award-group>
</funding-group>
<counts>
<page-count count="10"></page-count>
</counts>
</article-meta>
</front>
</article>
</pmc-articleset>